Skip to main content

Table 2 Radiation therapy

From: Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis

 

n

percentage

 

Conventional

54

93

 

Dose range

18-82Gy

Median

70Gy/35fx

AFX-CB

3

5

 

Dose range

60.8-76Gy

Median

67Gy

Accelerated hyperfractionation

1

2

 

Dose range

60Gy

Median

60Gy/40fx

  1. AFX-CB: accelerated fractionation with concomitant boost
Back to article page

Head & Neck Oncology

ISSN: 1758-3284